Elanco Animal Health Incorporated (ELAN)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 8% | 10% | 12% |
|---|---|---|---|
| 2% | $18 | $11 | $7 |
| 3% | $22 | $13 | $9 |
| 4% | $29 | $16 | $10 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $13 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XPH or MDYG, the fund manager is mechanically forced to buy or sell ELAN shares regardless of Elanco Animal Health Incorporated's individual fundamentals. We estimate $701M of passive capital is structurally linked to ELAN through 8 tracked ETFs. Passive flows have a limited but growing influence on ELAN's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Elanco Animal Health Incorporated to visualize passive redemption contagion across ETFs and collateral stocks.
If Elanco Animal Health Incorporated (ELAN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies FLEX LTD (FLEX) as the most exposed collateral stock, sharing 2 ETFs with ELAN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 13 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
ELAN Ownership Dynamics
ETFs with Highest ELAN Exposure
Float lock-up computed from 13 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
ELAN Capital Efficiency
How efficiently does Elanco Animal Health Incorporated convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Elanco Animal Health Incorporated converts 42% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 58% reinvestment rate signals aggressive capacity expansion.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-11 | 9,053 | $23.65 | $214,103.45 |
| 2026-05-08 | 33,904 | $24.01 | $814,035.04 |
| 2026-05-07 | 189,340 | $26.18 | $5.0M |
| 2026-05-04 | 42 | $22.51 | $945.42 |
| 2026-04-29 | 121 | $22.15 | $2,680.15 |
| 2026-04-28 | 3,788 | $22.09 | $83,676.92 |
| 2026-04-21 | 46,126 | $23.68 | $1.1M |
| 2026-04-20 | 44,750 | $23.68 | $1.1M |
| 2026-04-07 | 10 | $22.82 | $228.2 |
| 2026-04-02 | 865 | $23.12 | $19,998.8 |
| 2026-03-27 | 39 | $24.58 | $958.62 |
| 2026-03-25 | 57,789 | $24.90 | $1.4M |
| 2026-03-24 | 33,410 | $24.44 | $816,540.4 |
| 2026-03-23 | 41,374 | $23.98 | $992,148.52 |
| 2026-03-17 | 4,653 | $23.40 | $108,880.2 |
| 2026-03-13 | 12,688 | $22.68 | $287,763.84 |
| 2026-03-11 | 3 | $23.67 | $71.01 |
| 2026-03-03 | 1,669 | $26.09 | $43,544.21 |
| 2026-02-06 | 35,548 | $24.31 | $864,171.88 |
| 2026-01-30 | 759 | $24.20 | $18,367.8 |
| 2026-01-23 | 1,500 | $24.91 | $37,365 |
| 2026-01-20 | 56,945 | $24.53 | $1.4M |
| 2026-01-16 | 500 | $24.18 | $12,090 |
| 2026-01-15 | 16 | $24.44 | $391.04 |
| 2026-01-12 | 18,782 | $23.47 | $440,813.54 |
| 2026-01-07 | 1,327 | $23.80 | $31,582.6 |
| 2025-12-31 | 1,000 | $22.76 | $22,760 |
| 2025-12-30 | 549 | $22.65 | $12,434.85 |
| 2025-12-23 | 417,019 | $22.30 | $9.3M |
| 2025-12-22 | 140,162 | $22.30 | $3.1M |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare ELAN to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.